ERP29 over-expression significantly inhibits cell proliferation and suppresses tumorigenesis in breast cancer cells46, while its absence is associated with the progression, metastasis, and poor prognosis of gallbladder adenocarcinoma patients47. The gene discussed is ERP29; the disease is breast carcinoma.